Dr Reddy’s Laboratories Ltd announced the launch of the US Food and Drug Administration (USFDA) approved icosapent ethyl capsules, 1 gram
Dr Reddy’s icosapent ethyl capsules, 1 gram is approved for the indication of as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (= 500 mg/dL) hypertriglyceridemia.
The effect of icosapent ethyl capsules on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined.
Dr Reddy’s icosapent ethylis available in 1 gram capsules in bottle count size of 120’s count.
Cadila Pharma launches Posaconazole to treat fungal diseases
Cipla launches Vitamin C Chewable Tablets with Gold Supplement
Glenmark launches drug to treat Pulmonary disease in UK
Alkem launches Drug for Epilepsy treatment in India
Black Fungus: Mankind Pharma launches drug for treatment
Black fungus: SP Accure Labs launches Amphotericin B emulsion
Applications Forms: All types of Clinical Trials
Govt invites applications to manufacture Medical Device under PLI scheme
IPC to revise draft chapter on alternative Rapid Microbiological methods
European Commission approves Empagliflozin to treat heart failure
Synthetic Kidney can be created: Stem cell researchers
Common antibiotic useful in recovery of TB patients ?
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
